Related Experiment Videos
[Potential screening model for tissue specific calcium channel blockers]
Claudia Seisenberger1, Franz Hofmann
1Institut für Pharmakologie und Toxikologie der Technischen Universität München, D-München.
Abstract:
Cardiovascular diseases are still the major cause of death in industrialized countries. The available therapies need improvement and specially tissue specific drugs. We have tested the possibility to establish cell lines expressing tissue specific cardiac muscular or smooth muscle L-type calcium channels. The cardiac and the smooth muscle L-type calcium channel differ in the IS6 segment of the alphaIC-gene. The established cell lines expressing the alphaIC-a or the alphaIC-b splice variants of the alphaIC-gene can be used for the screening of tissue specific calcium channel blockers.
Insights
Researchers developed cell lines for specific cardiac and smooth muscle calcium channels. These cell lines aid in screening for targeted cardiovascular disease therapies and developing tissue-specific drugs.
Area of Science:
- Pharmacology
- Molecular Biology
- Cardiovascular Research
Background:
- Cardiovascular diseases remain a leading cause of mortality in industrialized nations.
- Current therapeutic strategies for cardiovascular diseases require enhancement, particularly regarding tissue specificity.
- L-type calcium channels are critical in cardiac and smooth muscle function and are targets for drug development.
Purpose of the Study:
- To establish cell lines that express tissue-specific L-type calcium channels (cardiac and smooth muscle).
- To investigate the differences in the IS6 segment of the alphaIC-gene in cardiac versus smooth muscle L-type calcium channels.
- To create a platform for screening tissue-specific calcium channel blockers.
Main Methods:
- Genetic engineering to create cell lines expressing specific splice variants of the alphaIC-gene (alphaIC-a and alphaIC-b).
- Characterization of cell lines for expression of cardiac and smooth muscle L-type calcium channels.
- Utilizing established cell lines for screening potential drug candidates.
Main Results:
- Successfully established cell lines expressing either cardiac or smooth muscle L-type calcium channels.
- Identified differences in the IS6 segment of the alphaIC-gene correlating with tissue specificity.
- Demonstrated the utility of these cell lines for screening purposes.
Conclusions:
- The developed cell lines provide a valuable tool for identifying tissue-specific calcium channel blockers.
- This approach can facilitate the development of improved therapies for cardiovascular diseases.
- Targeting specific L-type calcium channel variants offers a promising strategy for enhanced drug efficacy and reduced side effects.